Reaction

Gastroenteritis Rotavirus reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 304 reports · 4 co-occurring drugs

As of the last recalculation, Gastroenteritis Rotavirus appears in 304 FAERS reports alongside 4 co-occurring drug terms. The strongest observed disproportionality signal is PALIVIZUMAB (PRR 90.3).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Palivizumab1990.390.4
Thiotepa966.566.5
Fludarabine Phosphate2751.551.5
Pegaspargase528.428.4

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.